George Loo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
George Loo has a total of 83 co-authors. Here are the top co-authors by number of shared publications:
- Kimberly Souffront
Department of Emergency Medicine, Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Place New York, NY 10029, USA; Institute for Health Equity Research, Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Place New York, NY 10029, USA; Center for Nursing Research and Innovation, Mount Sinai Health System, 1 Gustave L. Levy Place New York, NY 10029, USA
6 shared publications - Lynne D. Richardson
Department of Emergency Medicine, Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Place New York, NY 10029, USA; Institute for Health Equity Research, Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Place New York, NY 10029, USA; Department of Population Health Science and Policy, 1 Gustave L. Levy Place New York, NY 10029, USA; Department of Artificial Intelligence and Human Health, 1468 Madison Ave 11th Floor New York, NY 10029, USA
4 shared publications - Lauren Gordon
Icahn School of Medicine at Mount Sinai, New York, New York, USA, mountsinai.org
3 shared publications Lynne D. Richardson
3 shared publications- Marcee Wilder
Department of Emergency Medicine, Icahn School of Medicine at Mount Sinai, New York, USA
3 shared publications - Aleksandra Degtyar
Interdisciplinary Collaborative Research Program (iCORE) Icahn School of Medicine at Mount Sinai US
2 shared publications
Latest Publications
- Open Access
- 19 January 2026
- Published by Levy Library Press in Journal of Scientific Innovation in Medicine
- Vol. 9 (1)
Social Determinants of Health and Uncontrolled Hypertension in Emergency Department Patients: A Multicenter Analysis
Objective: The role of social determinants of health (SDOH) among adult emergency department (ED) patients with hypertension remains largely unexplored. This study aims to address this critical knowledge gap. Methods: Electronic Health Record data from patients visiting six urban EDs between September 1, 2019, and October 21, 2022 with hypertension [Stage 1 hypertension (two blood pressure readings ≥ 130/80 mmHg)] or Stage 2 hypertension (≥140/90 mmHg)] were obtained along with their demographic and social characteristics such as employment, age, sex, insurance status and comorbidities. Bivariate analysis and multivariate regression modeled the odds of hypertension with demographic and social data, reported as odds ratios (OR) with 95% confidence intervals (CI). Results: Among 822,843 encounters, 22.8% (n = 187,664) involved patients with Stage 1 hypertension. These patients were middle-aged (mean age 60 years) and were more likely to have a prior diagnosis of hypertension (OR 3.02, 95% CI 2.96–3.09), be male (OR 1.14, 95% CI 1.12–1.14), African American (OR 1.40, 95% CI 1.37–1.42), and current smokers (OR 1.05, 95% CI 1.03–1.06), and less likely to be publicly insured (OR 0.91, 95% CI 0.89–0.92). Stage 2 hypertension occurred in 13.0% of encounters (n = 109,231). These patients had a similar mean age (63 years) and showed comparable associations, including higher odds of being African American (OR 1.61, 95% CI 1.58–1.64), unemployed (OR 0.50, 95% CI 0.47–0.52), having a prior hypertension diagnosis (OR 3.37, 95% CI 3.30–3.45), and smoking (OR 1.09, 95% CI 1.06–1.11). They were also less likely to be publicly insured (OR 0.91, 95% CI 0.89–0.93) or to present during the COVID period (OR 0.92, 95% CI 0.89–0.95). Conclusions: In this large, multicenter ED-based cohort, elevated blood pressure was consistently associated with key social and demographic factors, including race/ethnicity, insurance status, employment, and smoking. These findings underscore the importance of considering social context when evaluating hypertension in emergency department settings.
- 19 January 2026
- Published by Levy Library Press in Journal of Scientific Innovation in Medicine
- Vol. 9 (1)
Open AccessSocial Determinants of Health and Uncontrolled Hypertension in Emergency Department Patients: A Multicenter Analysis
Objective: The role of social determinants of health (SDOH) among adult emergency department (ED) patients with hypertension remains largely unexplored. This study aims to address this critical knowledge gap. Methods: Electronic Health Record data from patients visiting six urban EDs between September 1, 2019, and October 21, 2022 with hypertension [Stage 1 hypertension (two blood pressure readings ≥ 130/80 mmHg)] or Stage 2 hypertension (≥140/90 mmHg)] were obtained along with their demographic and social characteristics such as employment, age, sex, insurance status and comorbidities. Bivariate analysis and multivariate regression modeled the odds of hypertension with demographic and social data, reported as odds ratios (OR) with 95% confidence intervals (CI). Results: Among 822,843 encounters, 22.8% (n = 187,664) involved patients with Stage 1 hypertension. These patients were middle-aged (mean age 60 years) and were more likely to have a prior diagnosis of hypertension (OR 3.02, 95% CI 2.96–3.09), be male (OR 1.14, 95% CI 1.12–1.14), African American (OR 1.40, 95% CI 1.37–1.42), and current smokers (OR 1.05, 95% CI 1.03–1.06), and less likely to be publicly insured (OR 0.91, 95% CI 0.89–0.92). Stage 2 hypertension occurred in 13.0% of encounters (n = 109,231). These patients had a similar mean age (63 years) and showed comparable associations, including higher odds of being African American (OR 1.61, 95% CI 1.58–1.64), unemployed (OR 0.50, 95% CI 0.47–0.52), having a prior hypertension diagnosis (OR 3.37, 95% CI 3.30–3.45), and smoking (OR 1.09, 95% CI 1.06–1.11). They were also less likely to be publicly insured (OR 0.91, 95% CI 0.89–0.93) or to present during the COVID period (OR 0.92, 95% CI 0.89–0.95). Conclusions: In this large, multicenter ED-based cohort, elevated blood pressure was consistently associated with key social and demographic factors, including race/ethnicity, insurance status, employment, and smoking. These findings underscore the importance of considering social context when evaluating hypertension in emergency department settings.
- Open Access
- 1 January 2025
- Published by Wiley in International Journal of Hypertension
- Vol. 2025 (1)
B‐Type Natriuretic Peptide as a Marker of Subclinical Heart Disease in a High‐Burden Emergency Department Population With Sustained Asymptomatic Hypertension
B‐Type natriuretic peptide (BNP) levels below contemporary thresholds for diagnosing congestive heart failure are associated with subclinical heart disease (SHD) and adverse cardiovascular outcomes in community patients with uncontrolled asymptomatic hypertension. This study aimed to determine the accuracy of BNP for detecting SHD in emergency patients with sustained asymptomatic hypertension, where SHD is universally prevalent. Conducted at two urban academic emergency departments within a seven‐hospital healthcare organization, this proof‐of‐concept study included adults with sustained asymptomatic hypertension (initial BP ≥ 160/100 mmHg and second BP ≥ 140/90 mmHg), excluding those with congestive heart failure, renal insufficiency, atrial fibrillation, pregnancy, incarceration, cognitive impairment, and symptomatic hypertension. Enrolled patients underwent bedside echocardiograms, BNP lab tests, and electrocardiograms. All 78 patients (100%) had SHD. The cohort was predominantly female (55.1%), middle‐aged (mean age: 52 ± 15.2 years), with Class I obesity (mean BMI: 32.3 ± 8.3) and a high prevalence of hypertension history (55.1%). Common findings included left ventricular hypertrophy (86%), diastolic dysfunction (70.5%), and left ventricular systolic dysfunction (12.2%). The BNP lab test accurately detected SHD in nearly 60% of patients, with a Type II error rate of approximately 40%. In this proof‐of‐concept study, BNP underperformed in a cohort with universally present SHD, suggesting that sole reliance on BNP may lead to missed opportunities for early intervention.
- 1 January 2025
- Published by Wiley in International Journal of Hypertension
- Vol. 2025 (1)
Open AccessB‐Type Natriuretic Peptide as a Marker of Subclinical Heart Disease in a High‐Burden Emergency Department Population With Sustained Asymptomatic Hypertension
B‐Type natriuretic peptide (BNP) levels below contemporary thresholds for diagnosing congestive heart failure are associated with subclinical heart disease (SHD) and adverse cardiovascular outcomes in community patients with uncontrolled asymptomatic hypertension. This study aimed to determine the accuracy of BNP for detecting SHD in emergency patients with sustained asymptomatic hypertension, where SHD is universally prevalent. Conducted at two urban academic emergency departments within a seven‐hospital healthcare organization, this proof‐of‐concept study included adults with sustained asymptomatic hypertension (initial BP ≥ 160/100 mmHg and second BP ≥ 140/90 mmHg), excluding those with congestive heart failure, renal insufficiency, atrial fibrillation, pregnancy, incarceration, cognitive impairment, and symptomatic hypertension. Enrolled patients underwent bedside echocardiograms, BNP lab tests, and electrocardiograms. All 78 patients (100%) had SHD. The cohort was predominantly female (55.1%), middle‐aged (mean age: 52 ± 15.2 years), with Class I obesity (mean BMI: 32.3 ± 8.3) and a high prevalence of hypertension history (55.1%). Common findings included left ventricular hypertrophy (86%), diastolic dysfunction (70.5%), and left ventricular systolic dysfunction (12.2%). The BNP lab test accurately detected SHD in nearly 60% of patients, with a Type II error rate of approximately 40%. In this proof‐of‐concept study, BNP underperformed in a cohort with universally present SHD, suggesting that sole reliance on BNP may lead to missed opportunities for early intervention.
- Open Access
- 7 October 2024
- Published by Levy Library Press in Journal of Scientific Innovation in Medicine
- Vol. 7 (1)
Three Pilot Randomized Controlled Trials Evaluating a Persuasive Health Communication Intervention for Adult Emergency Department Patients Declining HIV/HCV Testing
The Journal of Scientific Innovation in Medicine is an open access, international, peer reviewed journal covering the range of transformative scientific developments from the bench, to the bedside, and to local and global communities with emphasis on new concepts and paradigms in the prevention and treatment of human disease and the creation of human health. The mission of this journal is twofold. First, we advance an understanding of how to apply new technology, scientific discovery and innovative solutions in order to expand the frontiers of medicine and health. The journal welcomes research pertaining to diagnostic and therapeutic discovery from clinicians, scientists and practitioners as they discover new ways to prevent and treat diseases and illnesses. The journal also welcomes research on the impact of scientific discovery on health care systems, public health and population health including costs, value, applicability and social determinants of health. In addition, the journal solicits original papers exploring attitudes towards health care innovation, exploring health technology assessment and the effect of new technology on patients and communities. Second, we provide a mentored learning environment in transformative and sustainable scholarly communication. We welcome submissions of papers from students, residents and fellows papers including those building on accepted conference abstracts. We encourage trainees to publish their work originating from evidence-based research to our constructive peer review process. Our editorial team blends students, trainees, librarians, and faculty with a wide range of authorship and editorial expertise in order that we provide mentored peer review learning opportunities. Supported by the Icahn School of Medicine at Mount Sinai and its Gustave L. and Janet W. Levy Library, the journal does not charge author submission/publication/processing fees and the content is open for all readers. To learn more about how to get involved with our open journals on the Levy Library Press, contact Kris Alpi, Associate Dean of Libraries & Information Sciences.
- 7 October 2024
- Published by Levy Library Press in Journal of Scientific Innovation in Medicine
- Vol. 7 (1)
Open AccessThree Pilot Randomized Controlled Trials Evaluating a Persuasive Health Communication Intervention for Adult Emergency Department Patients Declining HIV/HCV Testing
The Journal of Scientific Innovation in Medicine is an open access, international, peer reviewed journal covering the range of transformative scientific developments from the bench, to the bedside, and to local and global communities with emphasis on new concepts and paradigms in the prevention and treatment of human disease and the creation of human health. The mission of this journal is twofold. First, we advance an understanding of how to apply new technology, scientific discovery and innovative solutions in order to expand the frontiers of medicine and health. The journal welcomes research pertaining to diagnostic and therapeutic discovery from clinicians, scientists and practitioners as they discover new ways to prevent and treat diseases and illnesses. The journal also welcomes research on the impact of scientific discovery on health care systems, public health and population health including costs, value, applicability and social determinants of health. In addition, the journal solicits original papers exploring attitudes towards health care innovation, exploring health technology assessment and the effect of new technology on patients and communities. Second, we provide a mentored learning environment in transformative and sustainable scholarly communication. We welcome submissions of papers from students, residents and fellows papers including those building on accepted conference abstracts. We encourage trainees to publish their work originating from evidence-based research to our constructive peer review process. Our editorial team blends students, trainees, librarians, and faculty with a wide range of authorship and editorial expertise in order that we provide mentored peer review learning opportunities. Supported by the Icahn School of Medicine at Mount Sinai and its Gustave L. and Janet W. Levy Library, the journal does not charge author submission/publication/processing fees and the content is open for all readers. To learn more about how to get involved with our open journals on the Levy Library Press, contact Kris Alpi, Associate Dean of Libraries & Information Sciences.
- 24 September 2024
- Published by Elsevier in Journal of Emergency Nursing
- Vol. 51 (1) , 96-104
Brief Risk Communication for Emergency Department Patients With Sustained Asymptomatic Hypertension
- 24 September 2024
- Published by Elsevier in Journal of Emergency Nursing
- Vol. 51 (1) , 96-104
Brief Risk Communication for Emergency Department Patients With Sustained Asymptomatic Hypertension
- 1 September 2021
- Published by Elsevier in Journal of Emergency Nursing
- Vol. 47 (5) , 742-751.e1
System Level Informatics to Improve Triage Practices for Sickle Cell Disease Vaso-Occlusive Crisis: A Cluster Randomized Controlled Trial
- 1 September 2021
- Published by Elsevier in Journal of Emergency Nursing
- Vol. 47 (5) , 742-751.e1
System Level Informatics to Improve Triage Practices for Sickle Cell Disease Vaso-Occlusive Crisis: A Cluster Randomized Controlled Trial
- Open Access
- 1 October 2020
- Published by Elsevier in Annals of Emergency Medicine
- Vol. 76 (4) , S69
179 Ethnicity and Symptom Onset in the Emergency Department during the SARS-CoV-2 Pandemic at the “Epicenter of the Epicenter”
- 1 October 2020
- Published by Elsevier in Annals of Emergency Medicine
- Vol. 76 (4) , S69
Open Access179 Ethnicity and Symptom Onset in the Emergency Department during the SARS-CoV-2 Pandemic at the “Epicenter of the Epicenter”
- 1 July 2020
- Published by Elsevier in The Journal of Emergency Medicine
- Vol. 59 (1) , 147-152
Retrospective Cohort Study of Rates of Return Emergency Department Visits Among Patients Transported Home by Ambulance
- 1 July 2020
- Published by Elsevier in The Journal of Emergency Medicine
- Vol. 59 (1) , 147-152
Retrospective Cohort Study of Rates of Return Emergency Department Visits Among Patients Transported Home by Ambulance